ArticleFrontiers in oncology2021

Outstanding Response in a Patient With ROS1-Rearranged Inflammatory Myofibroblastic Tumor of Soft Tissues Treated With Crizotinib: Case Report.

Danila Comandini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.